AKU Clinical Trials Unit

The Clinical Trials Unit (CTU) is a center of excellence dedicated to conducting high-quality clinical trials that meet international standards. This state-of-the-art, 7,400 sq. ft. facility is specifically designed & approved by Drug Regulatory Authority of Pakistan (DRAP) for Phase I-IV clinical trials and is fully equipped to support every stage of clinical research. CTU has extensive experience in Phase II-IV pharmaceutical and device trials, as well as community-based studies with national and International Sponsors and Contract Research Organizations (CRO).

With a commitment to ICH-GCP compliance, CTU facilitates timely, high-quality research processes, aiming to improve healthcare access and outcomes for the population of Pakistan, and positively impact healthcare practices both nationally and internationally.